The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment.
Ontology highlight
ABSTRACT: Recently, in the field of cancer treatment, the paradigm has changed to immunotherapy that activates the immune system to induce cancer attacks. Among them, immune checkpoint inhibitors (ICI) are attracting attention as excellent and continuous clinical results. However, it shows not only limitations such as efficacy only in some patients or some indications, but also side-effects and resistance occur. Therefore, it is necessary to understand the factors of the tumor microenvironment (TME) that affect the efficacy of immunotherapy, that is, the mechanism by which cancer grows while evading or suppressing attacks from the immune system within the TME. Tumors can evade attacks from the immune system through various mechanisms such as restricting antigen recognition, inhibiting the immune sys
SUBMITTER: Kim SK
PROVIDER: S-EPMC9171538 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA